Alvespimycin Hydrochloride

N/A

Report date: 2024/07/05 11:15:08
NME

Base Information

Drug NameAlvespimycin Hydrochloride
Drug Alias Name阿螺旋霉素盐酸盐alvespimicinaalvespimycinum盐酸奥司匹霉素盐酸阿螺旋霉素 +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsSolid tumoursAngioimmunoblastic T-cell LymphomaGranuloma, Lethal Midline +[47] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer InstituteBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)Bristol Myers Squibb SrlcompanyNational Cancer Institute +[4] 
Active IndicationsN/A
Inactive IndicationsSolid tumoursAngioimmunoblastic T-cell LymphomaGranuloma, Lethal Midline +[47] 

Other Information

ATC CodeN/A
Related LinksN/A